Accession Number:

AD1004925

Title:

Immunomodulation to Optimize Vascularized Composite Allograft Integration in Limb Loss Therapy

Descriptive Note:

Technical Report,30 Sep 2014,29 Sep 2015

Corporate Author:

Duke University Durham United States

Personal Author(s):

• Cendales,Linda

Report Date:

2015-10-01

Pagination or Media Count:

6.0

Abstract:

The purpose of this study is to determine the safety and efficacy of hand transplantation as a treatment for patients with loss of limb below the elbow, The study will focus on patients who have had loss of limb. The primary endpoint is the ability to use the transplanted limb in activities of daily living at 18 months following transplantation measured by a quantitative functional test. Study activities include several study visits over 18 months and include demographics, medical history, vital signs, psychosocial evaluation, urine, blood test, chest x-ray, bone density scans, and biopsies. Subjects who are 18-65 and willing to travel to site and have loss of limb will be included in study evaluation.

Descriptors:

• TRANSPLANTATION
• SAFETY
• CLINICAL TRIALS
• AMPUTATION
• HANDS
• LIMBS
• WOUNDS AND INJURIES
• REPAIR
• REPLACEMENT
• REJECTION
• DRUGS
• CASUALTIES

Subject Categories:

Distribution Statement:

APPROVED FOR PUBLIC RELEASE